0 followers
Keapstone Therapeutics is a single asset biotech developing drugs that target the Nrf2 signalling pathway (KEAP1 inhibitors) for two devastating conditions – Parkinson’s and Motor Neuron Disease (MND) – which together affect more than 130,000 people in the UK. Keapstone was co-founded in February 20... Read more
This company has no org chart yet
This company has no teams yet
Autolus
3 followers
FUJIFILM Diosynth Biotechnologies
8 followers
Premier Research
2 followers
Queen Mary University
6 followers
Abzena
1 follower
Every Cure
1 follower
Amgen
234 followers
Fidelity International
7 followers
Avalere Health
3 followers
myPOS
3 followers
Thermo Fisher Scientific
179 followers
Explore companies